|
Volumn 163, Issue 1, 2012, Pages
|
Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
INOTROPIC AGENT;
ATHEROTHROMBOSIS;
BLEEDING;
BLOOD TRANSFUSION;
CANCER MORTALITY;
CAUSE OF DEATH;
CIGARETTE SMOKING;
COMBINATION CHEMOTHERAPY;
DIGESTIVE SYSTEM CANCER;
FLUID THERAPY;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
LETTER;
MONOTHERAPY;
MORTALITY;
PRIORITY JOURNAL;
STROKE;
THROMBOSIS;
ATHEROSCLEROSIS;
FEMALE;
HEMORRHAGE;
HUMANS;
MALE;
MYOCARDIAL ISCHEMIA;
PLATELET AGGREGATION INHIBITORS;
THROMBOSIS;
TICLOPIDINE;
|
EID: 83555162447
PISSN: 00028703
EISSN: 10976744
Source Type: Journal
DOI: 10.1016/j.ahj.2011.10.004 Document Type: Letter |
Times cited : (2)
|
References (8)
|